Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Assay test kits
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Assay test kits

[0597-V017-End-Point-48D] Falcon adenovirus detection Tests
Falcon adenovirus detection Tests
745.00 € 745.0 EUR
[0597-V017-One-Step-100D] Falcon adenovirus detection Tests
Falcon adenovirus detection Tests
1,172.50 € 1172.5 EUR
[0597-Oneq-V017-50R] Falcon adenovirus detection Tests
Falcon adenovirus detection Tests
1,492.00 € 1492.0 EUR
[0597- V017-One-Step-150D] Falcon adenovirus detection Tests
Falcon adenovirus detection Tests
1,291.00 € 1291.0 EUR
[0981-ED7042-T100] FagoFlowEx® Test, 100 Tests
FagoFlowEx® Test, 100 Tests
675.00 € 675.0 EUR
[0501-Kit-1054-100 Tests] Factor XIIa Activity Assay Test (Colorimetric) 100 Tests
Factor XIIa Activity Assay Test (Colorimetric) 100 Tests
2,338.00 € 2338.0 EUR
[0986-ab204696] Factor VIIIa Activity Assay Test (Fluorometric) - 100 Tests
Factor VIIIa Activity Assay Test (Fluorometric) - 100 Tests
814.00 € 814.0 EUR
[0441-T01101-96-S] FV (G1691A) Leiden SNP-Screen - 96 Tests
FV (G1691A) Leiden SNP-Screen - 96 Tests
560.00 € 560.0 EUR
[0544-MBS2508822-96T] FOXO3 elisa Test :: Human FOXO3 ELISA Test - 96 Tests
FOXO3 elisa Test :: Human FOXO3 ELISA Test - 96 Tests
830.00 € 830.0 EUR
[0763-E-AB-F0994C] FITC Anti-Mouse CD86 Antibody[GL-1] - 100 Tests
FITC Anti-Mouse CD86 Antibody[GL-1] - 100 Tests
162.00 € 162.0 EUR
[0246-981] FAM-FLIVO® In vivo Poly Caspase Assay - 24 Tests
FAM-FLIVO® In vivo Poly Caspase Assay - 24 Tests
723.00 € 723.0 EUR
[0246-913] FAM-FLICA® Caspase 9 Assay Test - 100 Tests
FAM-FLICA® Caspase 9 Assay Test - 100 Tests
890.00 € 890.0 EUR
[0246-910] FAM-FLICA® Caspase 8 Assay Test - 100 Tests
FAM-FLICA® Caspase 8 Assay Test - 100 Tests
890.00 € 890.0 EUR
[0037-30111-T] ExoBrite EV Membrane Staining Tests - 100 labelings, ExoBrite 410/450
ExoBrite EV Membrane Staining Tests - 100 labelings, ExoBrite 410/450
500.00 € 500.0 EUR
[0037-30112] ExoBrite CTB EV Staining Tests - 500 labelings, ExoBrite 490/515
ExoBrite CTB EV Staining Tests - 500 labelings, ExoBrite 490/515
970.00 € 970.0 EUR
[0037-30112-T] ExoBrite CTB EV Staining Tests - 100 labelings, ExoBrite 490/515
ExoBrite CTB EV Staining Tests - 100 labelings, ExoBrite 490/515
500.00 € 500.0 EUR
[0597-Oneq-V229-100R] Epizootic hemorrhagic disease virus detection Tests, one-step PCR, 100 rxn
Epizootic hemorrhagic disease virus detection Tests, one-step PCR, 100 rxn
1,749.00 € 1749.0 EUR
[0065-EFBA-100] EnzyFluo Total Bile Acid Test - 100 Tests
EnzyFluo Total Bile Acid Test - 100 Tests
671.00 € 671.0 EUR
[0065-ESOD-100] EnzyChrom Superoxide Dismutase Assay Test-100 Tests
EnzyChrom Superoxide Dismutase Assay Test-100 Tests
460.00 € 460.0 EUR
[0065-EPLP-100] EnzyChrom Phospholipid Assay Test 100 Tests
EnzyChrom Phospholipid Assay Test 100 Tests
851.00 € 851.0 EUR
  • 10
  • 11
  • 12
  • 13
  • 14

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)